2021 Digital Health Drug Development Telehealth 
Digital Health Global
NOVEMBER 2, 2023
Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates.
Lloyd Price
FEBRUARY 18, 2024
Companies with niche technologies or expertise: Startups with unique solutions in specific areas like AI-powered diagnostics, remote patient monitoring, or telehealth platforms. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
JUNE 17, 2023
The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.
Society for Participatory Medicine
JANUARY 27, 2022
Clinical trials, care encounters, and access to data were found guilty of not meeting patients where they are and not adequately addressing the social determinant of health factors, creating barriers for patients. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years.
Lloyd Price
FEBRUARY 22, 2024
Tech-driven Solutions: Digital Therapeutics (DTx): App-based solutions offering personalized pain management programs, education, and support. Telehealth: Remote consultations and monitoring for improved accessibility and convenience. In 2021, only 1.3% Subscribe Today! billion for oncology.
Expert insights. Personalized for you.
88 
Let's personalize your content